when to stop glp 1 for weight loss Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Half of GLP-1 users ditch

Many people miss this distinction upfront, so lets break both down clearly

For tirzepatide (Zepbound) Jastreboff and colleagues reported in the New England Journal of Medicine in 2022 that at maximal doses, the percent of individuals reporting side effects were as follows: Nausea 31.0% Diarrhea 23.0% Vomiting 12.2% Constipation 11.7% Bettge and colleagues conducted a study published in Diabetes, Obesity, and Metabolism in 2017 that showed that individuals who were taking metformin while taking a GLP-1 were more likely to have side effects, especially nausea and vomiting

Opens in new tab.

call 999 or go to A&E for chest pain, anaphylaxis, or sudden severe abdominal pain